Assessment of the safety of long-acting β<inf>2</inf> -agonists in routine asthma care : The ASTRO-LAB protocol
Citation
Van Ganse , E , Texier , N , Dima , A L , Laforest , L , Ferrer , M , Hernandez , G , Schuck , S , Herbage , S , Vial , D & De Bruin , M 2015 , ' Assessment of the safety of long-acting β <inf >2 </inf > -agonists in routine asthma care : The ASTRO-LAB protocol ' , npj Primary Care Respiratory Medicine , vol. 25 , 15040 . https://doi.org/10.1038/npjpcrm.2015.40
URI
http://hdl.handle.net/2164/4818http://www.scopus.com/inward/record.url?scp=84935005937&partnerID=8YFLogxK
Rights
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/